Machine Learning ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both… GlobeNewswire Apr 7, 2023 ProFound AI Risk offered higher accuracy than Tyrer-Cuzick v8 for all women, regardless of menopausal status, breast density, and family history of…
Machine Learning REVEAL GENOMICS´ Breakthrough Technology Enters the Liquid Biopsy Field in Oncology Business Wire Mar 10, 2023 REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, announced a…
Diagnosis Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in… AIT News Desk Mar 24, 2022 Paige Breast Lymph Node designed to enhance diagnostic accuracy and confidence detecting breast cancer metastases of any size in lymph node tissue…
Healthcare Management Transpara AI Breast Care – Global Expansion Planned for 2022 AIT News Desk Jan 19, 2022 ScreenPoint Medical Plans for major rollout across the US Following the success of the world's leading AI Breast Care system, Transpara, now in use…
Healthcare Management Roche Announces The Release Of Its Newest Artificial Intelligence Based Digital Pathology Algorithms… AIT News Desk Dec 7, 2021 Roche introduces three artificial intelligence (AI)-based, deep learning image analysis Research Use Only (RUO) algorithms developed for breast…
Healthcare Management Veracyte Announces Further European Reimbursement Expansion For Prosigna Breast Cancer Test AIT News Desk Nov 24, 2021 Only Test of Its Kind to Be Recommended for Use in All Swedish Healthcare Regions Without Restrictions Veracyte, Inc. announced that the Swedish…
Healthcare Management Perimeter Medical Imaging AI Announces Important Milestone In ATLAS AI Project With FDA… AIT News Desk Nov 4, 2021 Pivotal study to determine the impact of Perimeter’s novel OCT imaging technology combined with artificial intelligence on positive margin rates for…
Healthcare Management Menarini Group And Radius Health Announce Positive EMERALD Trial Results AIT News Desk Oct 21, 2021 - Menarini Group and Radius Health Announce Positive First-Line Phase 3 Results of the EMERALD Trial Evaluating Elacestrant in Breast Cancer - The…
Life Sciences Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging AIT News Desk Sep 24, 2021 A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a…
Healthcare Management Volpara Health Announces Jill Spear As New Executive Vice President Of Sales & Marketing AIT News Desk Jun 25, 2021 Breast Imaging Industry Expert will Focus on Expansion of Volpara's AI-Powered Breast Health Platform Volpara Health announced Jill Spear as the new…